drugset / Trial / NCT02848183
Optimal Treatment Strategy Based on for Pediatric AML
NaSingle-groupTreatment
Summary
The purpose of this study is to optimize therapy according to the known risk factors and treatment response in pediatric acute myeloid leukemia (AML)
Timeline
- Start
- 2016-01
- Primary completion
- 2020-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cytarabine | Small molecule | — | — |
| Subject | Etoposide | Small molecule | — | — |
| Subject | Idarubicin | Small molecule | — | — |
| Subject | Mitoxantrone | Small molecule | — | — |